A New Era in Cancer Care: How a Five-Minute Jab is Revolutionizing Treatment

Authors

  • Rajesh Elayedath Mahatma Gandhi University, Kerala, India
  • Fathima Naja MVR Cancer Centre and Research Institute, Kerala, India

DOI:

https://doi.org/10.3126/nje.v15i3.88668

Keywords:

Cancer, Nivolumab, Cancer treatment

Abstract

As there is an increased prevalence of cancer, healthcare systems must accommodate the growing number of patients without placing extra pressure on resources. If the NHS adheres to evidence-based, patient-led, and cost-effective modifications, the five-minute injection can represent the initiation, not only of a new era in cancer care, but also of an era of flexibility, humanity, and sustainability in the public health sector.

Downloads

Download data is not yet available.
Abstract
3
PDF
4

Author Biographies

Rajesh Elayedath, Mahatma Gandhi University, Kerala, India

Assistant Professor, School of Behavioural Sciences

Fathima Naja, MVR Cancer Centre and Research Institute, Kerala, India

Ex, Department of Clinical Pharmacy

Cover NJE

Downloads

Published

2025-12-31

How to Cite

Elayedath, R., & Naja, F. (2025). A New Era in Cancer Care: How a Five-Minute Jab is Revolutionizing Treatment. Nepal Journal of Epidemiology, 15(3), 1384–1385. https://doi.org/10.3126/nje.v15i3.88668

Issue

Vol. 15 No. 3 (2025)

Section

Editorial

License

Copyright (c) 2025 CEA & INEA

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  • Upon acceptance Copyright on any research article is transferred in full to the Confederation of Epidemiological Associations (CEA) and International Nepal Epidemiological Association (INEA).  The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
  • Articles in the Nepal Journal of Epidemiology are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
  • This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.